** BMO downgrades CSX CSX.O to "market perform" from "outperform", maintains PT at $38
** "We believe there is significant uncertainty surrounding key details of any potential deal involving CSX" - brokerage
** Sees BNSF merger deal as CSX's "best M&A scenario", adding that such a deal would have a greater chance of regulatory approval
** 18 of 28 brokerages rate the stock "buy" or higher, 10 "hold"; their median PT is $39 - data compiled by LSEG
** Including session's move, CSX up 12% YTD
(Reporting by Apratim Sarkar)
((Apratim.Sarkar@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.